Supplier
Doral Pharmaceuticals LLC
Doral Pharmaceuticals LLC was paid $3K by Medicaid between Nov 2021 and Nov 2023, across 5 billing codes. Its largest line is 90674, — 65% of everything it billed.
33Billing provider infoDORAL PHARMACEUTICALS LLC
PITTSBURGH, PA 15234
PITTSBURGH, PA 15234
33aNPI1013938075assigned 07/22/2006
33bProvider typePharmacy
28Total paid$3K
24GClaims182
24DCodes billed5
24AFirst – last monthNov 2021 – Nov 2023
Compared with peers
Next to other Pharmacy providers in Pennsylvania
Rank by total paid#29 of 51
Median peer was paid$4K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 74 | $723.35 | |
| 2022 | 17 | $51.33 | |
| 2023 | 91 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90674 | 65% | 62 | 61 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 26% | 64 | 60 | $774.68 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 9.3% | 29 | 28 | $277.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 15 | 14 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 12 | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEVANCIC, PRUDENCE (PRESIDENT)